BeginNGS® Consortium announces Alexion, AstraZeneca Rare Disease as its first Platinum member
San Diego—May 19, 2025–Rady Children’s Institute for Genomic Medicine (RCIGM®) today announced that Alexion, AstraZeneca Rare Disease has signed on as the first Platinum member of the BeginNGS (pronounced “beginnings”) Consortium, building on an existing nine-year collaboration which has catalyzed innovation in rare disease diagnostics.
The BeginNGS Consortium seeks to accelerate adoption of newborn screening by whole genome sequencing to identify babies at risk for hundreds of genetic diseases and recommend effective therapies before symptoms arise. Membership ...